Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Elixir pharmaceuticals, Inc. Proposed Ticker ELXR CUSIP 28660Q104 Business Description A Pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. Lead Underwriter Credit Suisse Co-Managers Pacific Growth Equities, LLC, Leerink Swann Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price $9.00-$11.00 Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.